Stock Fundamentals

Company Information

Company Name
Protara Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US74365U1079
CIK: 0001359931
CUSIP: 04300J107
Currency: USD
Full Time Employees: 46
Phone: 646 844 0337
Fiscal Year End: December
IPO Date: Oct 22, 2014
Description:

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.

Address:

345 Park Avenue South, New York, NY, United States, 10010

Directors & Officers

Name Title Year Born
Mr. Jesse Shefferman Co-founder, CEO, President & Director 1972
Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D. Co-Founder, Chief R&D Officer 1981
Dr. Leonardo Viana Nicacio M.D. Chief Medical Officer 1978
Mr. Patrick Fabbio M.B.A. Chief Financial Officer 1968
Ms. Hannah Fry VP, Principal Accounting Officer & Controller 1991
Ms. Justine O'Malley Senior Vice President of Investor Relations & Corporate Affairs NA
Ms. Mary J. Grendell J.D. General Counsel & Corporate Secretary NA
Dr. Shane Williams Ph.D. Chief People Officer NA
Dr. Neal D. Shore F.A.C.S., M.D. Medical Director of START Carolinas/ Carolina Urologic Research Center NA
Carla Beckham M.D., Ph.D. Lead Medical Director, Head of Clinical Development of TARA-002 in NMIBC & Board-Certified Urologist NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 08, 2026 Jacqueline Zummo N/A Sale 1.13K $5.40 $6.12K
Apr 01, 2026 Jacqueline Zummo N/A Sale 22.60K $5.26 $118.87K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
HHG PLC 5.21M Mar 31, 2026 9.26% $0.01 1.27%
BlackRock Inc 3.39M Mar 31, 2026 6.04% $0.00 40.94%
Velan Capital Investment Management LP 2.83M Mar 31, 2026 5.04% $9.25 0.00%
Millennium Management LLC 2.83M Mar 31, 2026 5.04% $0.01 275.84%
Vanguard Group Inc 2.39M Dec 31, 2025 4.26% $0.00 25.61%
Blackstone Inc 2.27M Mar 31, 2026 4.03% $0.05 18.63%
Vanguard Capital Management, LLC 2.12M Mar 31, 2026 3.77% $0.00 0.00%
Sio Capital Management, LLC 1.97M Mar 31, 2026 3.50% $1.47 14.83%
Integral Health Asset Management, LLC 1.75M Mar 31, 2026 3.11% $0.44 -22.22%
AIGH Capital Management, LLC 1.62M Mar 31, 2026 2.89% $1.15 0.00%
UBS Group AG 1.40M Mar 31, 2026 2.50% $0.00 15.37%
5AM Venture Management, LLC 1.37M Mar 31, 2026 2.44% $1.98 0.00%
Geode Capital Management, LLC 1.18M Mar 31, 2026 2.09% $0.00 44.05%
Point72 Asset Management, L.P. 1.15M Mar 31, 2026 2.05% $0.01 4,001.16%
Citadel Advisors Llc 1.07M Mar 31, 2026 1.90% $0.00 18.53%
Patient Square Capital LP 1.03M Mar 31, 2026 1.83% $0.95 0.00%
State Street Corp 1.01M Mar 31, 2026 1.79% $0.00 76.07%
Baker Bros Advisors LP 971.61K Mar 31, 2026 1.73% $0.03 0.00%
ADAR1 Capital Management LLC 940.51K Mar 31, 2026 1.67% $0.29 -17.27%
Bank of America Corp 925.92K Mar 31, 2026 1.65% $0.00 86.71%

Shares Statistics

Shares Outstanding: 56.20M
Shares Float: 49.46M
% Insiders: 242.10%
% Institutions: 8,236.00%
Short % Float: 10.66%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.54M 2.74% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 1.23M 2.19% ▲ 0.93% May 29, 2026
3 Vanguard Institutional Extnd Mkt Idx Tr 522.15K 0.93% ▲ 0.00% Apr 30, 2026
4 Fidelity Small Cap Index 504.70K 0.90% ▲ 45.79% Mar 31, 2026
5 iShares Russell 2000 Value ETF 434.35K 0.77% ▲ 0.00% May 29, 2026
6 State St Russell Sm/Mid Cp® Indx SL Cl I 302.00K 0.54% ▲ 0.00% May 31, 2026
7 Vanguard Russell 2000 ETF 259.40K 0.46% ▲ 2.92% Apr 30, 2026
8 Fidelity Extended Market Index 252.63K 0.45% ▼ 0.36% Apr 30, 2026
9 State St Russell Sm Cap® Idx SL Cl I 199.20K 0.35% ▲ 0.00% May 31, 2026
10 Russell 2000 Equity Index Fund B 197.06K 0.35% ▲ 0.04% Dec 31, 2025

Valuation Metrics

Enterprise Value: $85.91M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $219.20M
EBITDA: $-69.69M
Book Value: $3.67
Earnings/Share: $-1.36
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -24.29%
ROE (TTM): -37.27%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 14.58x 0.01x 0.06x N/A -0.02x
2024-12-31 15.71x 0.01x 0.08x -11.78x -0.03x
2023-12-31 11.17x 0.01x 0.13x N/A -0.02x
2022-12-31 15.01x 0.01x 0.10x -58.98x -0.01x
2021-12-31 21.66x 0.01x 0.06x -27.34x -0.02x
2020-12-31 58.13x 0.00x 0.02x -1,013.06x 0.00x
2019-12-31 11.96x 0.00x 0.08x N/A 0.00x
2018-12-31 7.55x 0.00x 0.13x N/A 0.00x
2017-12-31 4.71x 0.00x 0.21x -117.23x 0.00x
2016-12-31 8.42x 0.00x 0.12x -148.73x 0.00x
2015-12-31 16.12x 0.00x 0.06x -144.93x 0.00x
2014-12-31 36.19x 0.00x 0.03x -8.84x 0.00x
2013-12-31 0.55x -1.23x 1.73x -8.27x -0.72x
2012-12-31 6.40x 0.00x 0.53x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TARA.US!